Agency Forms Undergoing Paperwork Reduction Act Review, 4924-4925 [2015-01652]

Download as PDF 4924 Federal Register / Vol. 80, No. 19 / Thursday, January 29, 2015 / Notices mstockstill on DSK4VPTVN1PROD with NOTICES selected to serve the interests of the blood, blood products, tissue and organ professional organizations or business sectors. The representative members are selected from the following groups: The AABB (formerly the American Association of Blood Banks); American Association of Tissue Banks; Eye Bank Association of America; Association of Organ Procurement Organizations; and one of either the American National Red Cross or America’s Blood Centers on a rotating basis. The Committee composition can include additional representation from either the plasma protein fraction community or a trade organization; a manufacturer of blood, plasma, or other tissue/organ test kits; a manufacturer of blood, plasma or other tissue/organ equipment; a major hospital organization; or a major hospital accreditation organization. Where more than one company produces a specified product or process, representatives from those companies shall rotate on the same schedule as public members. All ACBTSA members are authorized to receive the prescribed per diem allowance and reimbursement for travel expenses that are incurred to attend meetings and conduct Committeerelated business, in accordance with Standard Government Travel Regulations. Individuals who are appointed to serve as public members are authorized also to receive a stipend for attending Committee meetings and to carry out other Committee-related business. Individuals who are appointed to serve as representative members for a particular interest group or industry are not authorized to receive a stipend for the performance of these duties. This announcement is to solicit nominations of qualified candidates to fill nine public member positions that are scheduled to be vacated on the ACBTSA. Nominations In accordance with the charter, persons nominated for appointment as members of the ACBTSA should be among authorities knowledgeable in blood banking, tissue banking, transfusion medicine, organ or tissue transplantation, plasma therapies, transfusion and transplantation safety, bioethics, and/or related disciplines. Nominations should be typewritten. The following information should be included in the package of material submitted for each individual being nominated for consideration of appointment: (a) The name, return address, daytime telephone number and affiliation(s) of the individual being nominated, the basis for the individual’s VerDate Sep<11>2014 18:16 Jan 28, 2015 Jkt 235001 nomination, the category for which the individual is being nominated, and a statement bearing an original signature of the nominated individual that, if appointed, he or she is willing to serve as a member of the Committee; (b) the name, return address, and daytime telephone number at which the nominator may be contacted. Organizational nominators must identify a principal contact person in addition to the contact; and (c) a copy of a current curriculum vitae or resume for the nominated individual. Individuals can nominate themselves for consideration of appointment to the Committee. All nominations must include the required information. Incomplete nominations will not be processed for consideration. The letter from the nominator and certification of the nominated individual must bear original signatures; reproduced copies of these signatures are not acceptable. The Department is legally required to ensure that the membership of HHS Federal advisory committees is fairly balanced in terms of points of view represented and the functions to be performed by the advisory committee. Every effort is made to ensure that the views of women, all ethnic and racial groups, and people with disabilities are represented on HHS Federal Advisory committees and, therefore, the Department encourages nominations of qualified candidates from these groups. The Department also encourages geographic diversity in the composition of the committee. Appointment to this Committee shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, disability, and cultural, religious, or socioeconomic status. The Standards of Ethical Conduct for Employees of the Executive Branch are applicable to individuals who are appointed as public members of Federal advisory committees. Individuals appointed to serve as public members of Federal advisory committees are classified as special government employees (SGEs). The federal conflict of interest laws are applicable to SGEs. Therefore, individuals appointed to serve as public members of the ACBTSA are subject to an ethics review. The ethics review is conducted to determine if the individual has any interests and/ or activities in the private sector that may conflict with performance of their official duties as a member of the Committee. Individuals appointed to serve as public members of the committee will be required to disclose information regarding financial holdings, consultancies, and research grants and/or contracts. PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 Dated: January 22, 2015. James J. Berger, Senior Advisor for Blood and Tissue Policy. [FR Doc. 2015–01682 Filed 1–28–15; 8:45 am] BILLING CODE 4150–41–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30-Day–15–0931] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The notice for the proposed information collection is published to obtain comments from the public and affected agencies. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address any of the following: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570 or send an email to omb@cdc.gov. Written comments and/or suggestions regarding the items contained in this notice should be directed to the Attention: CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. E:\FR\FM\29JAN1.SGM 29JAN1 4925 Federal Register / Vol. 80, No. 19 / Thursday, January 29, 2015 / Notices Proposed Project Healthy Homes and Lead Poisoning Prevention Surveillance System (HHLPPSS)(OMB Control No. 0920– 0931, Expiration April 30, 2015)— Extension—National Center for Environmental Health (NCEH) and Agency for Toxic Substances and Disease Registry (ATSDR), Centers for Disease Control and Prevention (CDC). Background and Brief Description The overarching goal of the Healthy Homes and Lead Poisoning Prevention Surveillance System (HHLPPSS) is to support healthy homes surveillance activities at the state and national levels. HHLPSS is not a research study; rather it is a systematic assessment of programmatic activities under the healthy homes cooperative agreement. CDC is requesting a three-year extension of Office of Management and Budget (OMB) approval for up to 40 local and state Healthy Homes Childhood Lead Poisoning Prevention Programs (CLPPP) and the state-based Adult Blood Lead Epidemiology and Surveillance (ABLES) programs. The programs will continue to report information (e.g., presence of lead paint, age of housing, occupation of adults and type of housing) via encrypted files and submit, electronically, to HHLPPB staff at CDC. The electronic files will be kept in accordance with CDC Records Control Schedules. Over the last three years, 7 states have adopted the HHLPPSS and 13 are in beta-testing. In October 2014, CDC began funding 40 state and local blood lead surveillance programs. Many of these programs and their subcontractors at the local level will come on line with HHLPPSS in the next year. The objectives for this surveillance system are two-fold. First, the HHLPPSS allows CDC to systematically track how the state and local programs conduct case management and follow-up of residents with housing-related health outcomes. Second, the system allows for identification and collection of information on other housing-related risk factors. Childhood and adult lead poisoning is just one of many adverse health conditions that are related to common housing deficiencies. Multiple hazards in housing (e.g., mold, vermin, radon and the lack of safety devices) continue to adversely affect the health of residents. HHLPPSS offers a coordinated, comprehensive, and systematic public health approach to eliminate multiple housing-related health hazards. HHLPPSS enables flexibility to evaluate housing where the risk for lead poisoning is high, regardless of whether children less than 6 years of age currently reside there. Thus, HHLPPSS supports CDC efforts for primary prevention of childhood and adult lead poisoning. Over the past several decades there has been a remarkable reduction in environmental sources of lead, improved protection from occupational lead exposure, and an overall decreasing trend in the prevalence of elevated blood lead levels (BLLs) in U.S. adults. As a result, the U.S. national BLL geometric mean among adults was 1.2 mg/dL during 2009–2010. Nonetheless, lead exposures continue to occur at unacceptable levels. Current research continues to find that BLLs previously considered harmless can have harmful effects in adults, such as decreased renal function and increased risk for hypertension and essential tremor at BLLs <10 mg/dL. There is no cost to respondents other than their time. The total estimated annual burden hours are 640. ESTIMATED ANNUALIZED BURDEN HOURS Type of respondents Form name Number of respondents Number of responses per respondent Average burden per response (in hours) State and Local Health Departments ............. Healthy Homes and Lead Poisoning Prevention Surveillance Variables (HHLPPSS). 40 4 4 Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2015–01652 Filed 1–28–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families mstockstill on DSK4VPTVN1PROD with NOTICES Proposed Information Collection Activity; Comment Request Proposed Projects Title: Refugee Microenterprise and Refugee Home-Based Child Care Microenterprise Development Programs OMB No.: 0970 Description: The Office of Refugee Resettlement (ORR) within the VerDate Sep<11>2014 18:16 Jan 28, 2015 Jkt 235001 Administration for Children and families (ACF) is responsible for resettling thousands of refugees every year from all over the world. The main goal of the ORR (US) refugee domestic resettlement program is to assist the refugees in becoming self-reliant at the shortest time possible. ORR has many different discretionary grants that it employs to accomplish this goal. Two of the discretionary grants are the Refugee Microenterprise Development (MED) and the Refugee Home-Based Child Care Microenterprise Development (HBCC MED) Programs. The goals of the MED program are to assist refugees in becoming economically self-sufficient, assist refugee serving organizations galvanize resources to strengthen their capacities to expand and continue their microenterprise services at an expanded and sustainable level, and enhance the integration to the mainstream and realize the American Dream. The focus of the HBCC Program is on women that PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 have limited opportunity to get employment at livable wages because of limited transferable skills and lack of knowledge of the English language. Through the program women refugees are provided basic training in child care and development, state and local legal requirements to get a license and to establish a home-based child care service. The ultimate goal of the program is to enable the women refugees establish a home-based child care service in their neighborhood. ORR works with nonprofit organizations in implementing these projects. Currently, there are 22 projects in the Refugee Microenterprise Development Program and 23 projects in the Refugee Home-Based Child Care Microenterprise Development Program. It is critical to collect data through a semi-annual report in order to determine whether or not the programs are achieving their intended goals, to address concerns, issues, and challenges E:\FR\FM\29JAN1.SGM 29JAN1

Agencies

[Federal Register Volume 80, Number 19 (Thursday, January 29, 2015)]
[Notices]
[Pages 4924-4925]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-01652]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30-Day-15-0931]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention: CDC Desk Officer, Office of Management and 
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written 
comments should be received within 30 days of this notice.

[[Page 4925]]

Proposed Project

    Healthy Homes and Lead Poisoning Prevention Surveillance System 
(HHLPPSS)(OMB Control No. 0920-0931, Expiration April 30, 2015)--
Extension--National Center for Environmental Health (NCEH) and Agency 
for Toxic Substances and Disease Registry (ATSDR), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    The overarching goal of the Healthy Homes and Lead Poisoning 
Prevention Surveillance System (HHLPPSS) is to support healthy homes 
surveillance activities at the state and national levels. HHLPSS is not 
a research study; rather it is a systematic assessment of programmatic 
activities under the healthy homes cooperative agreement. CDC is 
requesting a three-year extension of Office of Management and Budget 
(OMB) approval for up to 40 local and state Healthy Homes Childhood 
Lead Poisoning Prevention Programs (CLPPP) and the state-based Adult 
Blood Lead Epidemiology and Surveillance (ABLES) programs. The programs 
will continue to report information (e.g., presence of lead paint, age 
of housing, occupation of adults and type of housing) via encrypted 
files and submit, electronically, to HHLPPB staff at CDC. The 
electronic files will be kept in accordance with CDC Records Control 
Schedules.
    Over the last three years, 7 states have adopted the HHLPPSS and 13 
are in beta-testing. In October 2014, CDC began funding 40 state and 
local blood lead surveillance programs. Many of these programs and 
their subcontractors at the local level will come on line with HHLPPSS 
in the next year.
    The objectives for this surveillance system are two-fold. First, 
the HHLPPSS allows CDC to systematically track how the state and local 
programs conduct case management and follow-up of residents with 
housing-related health outcomes. Second, the system allows for 
identification and collection of information on other housing-related 
risk factors. Childhood and adult lead poisoning is just one of many 
adverse health conditions that are related to common housing 
deficiencies. Multiple hazards in housing (e.g., mold, vermin, radon 
and the lack of safety devices) continue to adversely affect the health 
of residents. HHLPPSS offers a coordinated, comprehensive, and 
systematic public health approach to eliminate multiple housing-related 
health hazards.
    HHLPPSS enables flexibility to evaluate housing where the risk for 
lead poisoning is high, regardless of whether children less than 6 
years of age currently reside there. Thus, HHLPPSS supports CDC efforts 
for primary prevention of childhood and adult lead poisoning. Over the 
past several decades there has been a remarkable reduction in 
environmental sources of lead, improved protection from occupational 
lead exposure, and an overall decreasing trend in the prevalence of 
elevated blood lead levels (BLLs) in U.S. adults. As a result, the U.S. 
national BLL geometric mean among adults was 1.2 [micro]g/dL during 
2009-2010. Nonetheless, lead exposures continue to occur at 
unacceptable levels. Current research continues to find that BLLs 
previously considered harmless can have harmful effects in adults, such 
as decreased renal function and increased risk for hypertension and 
essential tremor at BLLs <10 [micro]g/dL.
    There is no cost to respondents other than their time. The total 
estimated annual burden hours are 640.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                   Number of     Average  burden
         Type of respondents                 Form name            Number of      responses per    per  response
                                                                 respondents       respondent       (in hours)
----------------------------------------------------------------------------------------------------------------
State and Local Health Departments..  Healthy Homes and Lead               40                4                4
                                       Poisoning Prevention
                                       Surveillance Variables
                                       (HHLPPSS).
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-01652 Filed 1-28-15; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.